Riccobene T - Search Results

1

Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.

Li J, Lovern M, Green ML, Chiu J, Zhou D, Comisar C, Xiong Y, Hing J, MacPherson M, Wright JG, Riccobene T, Carrothers TJ, Das S. Li J, et al. Among authors: riccobene t. Clin Transl Sci. 2019 Mar;12(2):151-163. doi: 10.1111/cts.12585. Epub 2018 Sep 28. Clin Transl Sci. 2019. PMID: 30221827 Free PMC article.

2

Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.

Mawal Y, Critchley IA, Riccobene TA, Talley AK. Mawal Y, et al. Expert Rev Clin Pharmacol. 2015;8(6):691-707. doi: 10.1586/17512433.2015.1090874. Epub 2015 Sep 30. Expert Rev Clin Pharmacol. 2015. PMID: 26420166 Review.

3

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.

Riccobene TA, Khariton T, Knebel W, Das S, Li J, Jandourek A, Carrothers TJ, Bradley JS. Riccobene TA, et al. J Clin Pharmacol. 2017 Mar;57(3):345-355. doi: 10.1002/jcph.809. Epub 2016 Sep 27. J Clin Pharmacol. 2017. PMID: 27510635

4

Avibactam Pharmacokinetic/Pharmacodynamic Targets.

Nichols WW, Newell P, Critchley IA, Riccobene T, Das S. Nichols WW, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2018 May 25;62(6):e02446-17. doi: 10.1128/AAC.02446-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29610208 Free PMC article. Review.

5

Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.

Nichols WW, Stone GG, Newell P, Broadhurst H, Wardman A, MacPherson M, Yates K, Riccobene T, Critchley IA, Das S. Nichols WW, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e02590-17. doi: 10.1128/AAC.02590-17. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30061279 Free PMC article.

6

Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.

Das S, Li J, Riccobene T, Carrothers TJ, Newell P, Melnick D, Critchley IA, Stone GG, Nichols WW. Das S, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02187-18. doi: 10.1128/AAC.02187-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670413 Free PMC article. Review.

7

Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.

Li J, Lovern M, Riccobene T, Carrothers TJ, Newell P, Das S, Talley AK, Tawadrous M. Li J, et al. Among authors: riccobene t. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02105-19. doi: 10.1128/AAC.02105-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015049 Free PMC article. Review.

8

Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.

Riccobene TA, Carrothers TJ, Knebel W, Raber S, Chan PLS. Riccobene TA, et al. Clin Pharmacol Drug Dev. 2021 Apr;10(4):420-427. doi: 10.1002/cpdd.907. Epub 2021 Jan 19. Clin Pharmacol Drug Dev. 2021. PMID: 33465279 Free PMC article.

9

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

Esposito S, Carrothers TJ, Riccobene T, Stone GG, Kantecki M. Esposito S, et al. Among authors: riccobene t. Paediatr Drugs. 2021 Nov;23(6):549-563. doi: 10.1007/s40272-021-00468-w. Epub 2021 Aug 31. Paediatr Drugs. 2021. PMID: 34462863 Free PMC article. Review.

10

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

Esposito S, Carrothers TJ, Riccobene T, Stone GG, Kantecki M. Esposito S, et al. Among authors: riccobene t. Paediatr Drugs. 2021 Nov;23(6):615. doi: 10.1007/s40272-021-00474-y. Paediatr Drugs. 2021. PMID: 34617260 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page